EDUARDO ESPIRIDION: Open Payments
NPI 1538165964 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 6 payments from 5 companies in 2025. Trend: 2023 $22 · 2024 $629 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $165 |
| Neurocrine BioSciences, Inc. | 2 | $163 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $64 |
| Avion Pharmaceuticals | 1 | $54 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, INGREZZA, ABILIFY MAINTENA, COBENFY, Relexxii.
Industry payments across MD — which companies pay providers there.
